Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick S Barrett

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Trends in Cognitive Sciences|October 3, 2022
A role for the claustrum in cognitive controlMaxwell B Madden, Brent W Stewart, Michael G White, et al.
Journal of Addiction Medicine|August 10, 2016
Brief Opioid Overdose Knowledge (BOOK): A Questionnaire to Assess Overdose Knowledge in Individuals Who Use Illicit or Prescribed OpioidsKelly E Dunn, Frederick S Barrett, Claudia Yepez-Laubach, et al.
International Journal of Methods in Psychiatric Research|April 26, 2026
Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsKurt Stocker, Matthias Hartmann, Frederick S Barrett, et al.
Plos One|March 14, 2024
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderAdam W Levin, Rafaelle Lancelotta, Nathan D Sepeda, et al.
JAMA Psychiatry|November 4, 2020
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical TrialAlan K Davis, Frederick S Barrett, Darrick G May, et al.
Scientific Reports|October 3, 2020
The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human BrainManoj K Doss, Darrick G May, Matthew W Johnson, et al.
The International Journal of Neuropsychopharmacology|May 14, 2021
Psychedelics and Consciousness: Distinctions, Demarcations, and OpportunitiesDavid B Yaden, Matthew W Johnson, Roland R Griffiths, et al.
Journal of Psychopharmacology (Oxford, England)|November 29, 2024
Psychedelic risks and benefits: A cross-sectional survey studySean P Goldy, Benjamin A Du, Julia S Rohde, et al.
Journal of Psychopharmacology (Oxford, England)|October 13, 2017
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviorsRoland R Griffiths, Matthew W Johnson, William A Richards, et al.
Psychiatry Research|February 26, 2026
Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy onesSean P Goldy, Nathan D Sepeda, Samantha N Hilbert, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Trends in Cognitive Sciences|October 3, 2022
A role for the claustrum in cognitive controlMaxwell B Madden, Brent W Stewart, Michael G White, et al.
Journal of Addiction Medicine|August 10, 2016
Brief Opioid Overdose Knowledge (BOOK): A Questionnaire to Assess Overdose Knowledge in Individuals Who Use Illicit or Prescribed OpioidsKelly E Dunn, Frederick S Barrett, Claudia Yepez-Laubach, et al.
International Journal of Methods in Psychiatric Research|April 26, 2026
Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsKurt Stocker, Matthias Hartmann, Frederick S Barrett, et al.
Plos One|March 14, 2024
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderAdam W Levin, Rafaelle Lancelotta, Nathan D Sepeda, et al.
JAMA Psychiatry|November 4, 2020
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical TrialAlan K Davis, Frederick S Barrett, Darrick G May, et al.
Scientific Reports|October 3, 2020
The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human BrainManoj K Doss, Darrick G May, Matthew W Johnson, et al.
The International Journal of Neuropsychopharmacology|May 14, 2021
Psychedelics and Consciousness: Distinctions, Demarcations, and OpportunitiesDavid B Yaden, Matthew W Johnson, Roland R Griffiths, et al.
Journal of Psychopharmacology (Oxford, England)|November 29, 2024
Psychedelic risks and benefits: A cross-sectional survey studySean P Goldy, Benjamin A Du, Julia S Rohde, et al.
Journal of Psychopharmacology (Oxford, England)|October 13, 2017
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviorsRoland R Griffiths, Matthew W Johnson, William A Richards, et al.
Psychiatry Research|February 26, 2026
Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy onesSean P Goldy, Nathan D Sepeda, Samantha N Hilbert, et al.
Pageof 8